The efficacy and mortality outcomes of Clopidogrel and ticagrelor in patients with acute coronary syndromes (ACS)

Trial Profile

The efficacy and mortality outcomes of Clopidogrel and ticagrelor in patients with acute coronary syndromes (ACS)

Completed
Phase of Trial: Phase IV

Latest Information Update: 27 Dec 2016

At a glance

  • Drugs Clopidogrel (Primary) ; Ticagrelor (Primary)
  • Indications Acute coronary syndromes
  • Focus Therapeutic Use
  • Acronyms CATH SHAMI study
  • Most Recent Events

    • 27 Dec 2016 New trial record
    • 01 Nov 2016 Results published in the Journal of the American College of Cardiology
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top